Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

237.93
Delayed Data
As of Aug 26
 +1.62 / +0.69%
Today’s Change
195.50
Today|||52-Week Range
322.68
-23.86%
Year-to-Date
Allergan: An Undervalued Powerhouse
2:02pm / GuruFocus News - Paid Partner Content
Which Criteria Best Determine the Success of Mergers?
Aug 24 / GuruFocus News - Paid Partner Content
Hedge Funds Love Liberty and John Malone
Aug 26 / GuruFocus News - Paid Partner Content
5 Things You Must Know Before the Market Opens Wednesday
Aug 24 / TheStreet.com - Paid Partner Content
FTC Details Concerns on Generic Drug Company Mergers
Aug 26 / TheStreet.com - Paid Partner Content
Pfizer Picks Up AstraZeneca's Antibiotics Business
Aug 24 / TheStreet.com - Paid Partner Content
Cempra's Application for Pneumonia Drug Validated in EU
Aug 24 / Zacks.com - Paid Partner Content
3 Stocks Billionaires Are Buying
Aug 23 / MotleyFool.com - Paid Partner Content
Dear Pfizer, Stop Overpaying for Acquisitions!
Aug 24 / MotleyFool.com - Paid Partner Content
Congress Demand An Explanation For Epipen Price Increases; Mylan Slides
Aug 22 / Investing Channel - Paid Partner Content

Today’s Trading

Previous close236.31
Today’s open236.68
Day’s range235.74 - 239.12
Volume3,450,762
Average volume (3 months)3,474,660
Market cap$94.2B
Dividend yield--
Data as of 4:01pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+4.88%
Earnings growth (next 5 years)+12.80%
Revenue growth (last year)+15.38%
P/E ratioNM
Price/Sales7.63
Price/Book1.31

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+0.04+0.09%
BMYBristol-Myers Squibb+0.01+0.02%
SNYSanofi+0.34+0.88%
LLYEli Lilly and Co+0.23+0.29%
Data as of 4:02pm ET, 08/26/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)$3.64
Annual revenue (last year)$15.1B
Annual profit (last year)$3.9B
Net profit margin-19.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs